Eblasakimab Antibody
Eblasakimab (ASLAN004) is a humanized monoclonal antibody designed to inhibit the IL-13 receptor alpha subunit, thereby blocking signaling of IL-4 and IL-13 through the type 2 receptor. This mechanism makes it a relevant tool for investigating the pathophysiology and potential therapeutic strategies for atopic dermatitis in both in vitro and in vivo research models.
Product Specifications
Product Name Alternative
CSL334, CSL-334, ASLA N004, ASLAN004
Target
Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
7.31 mg/mL
Purity
98.18% (May vary between batches)
Molecular Weight
143.86 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2940877-01 250 mg
4-Methylumbelliferyl β-D-N, N', N'', N'''-tetraacetylchitotetraoside
Sign In for Pricing
View Details orb2940877-02 50 mg
4-Methylumbelliferyl β-D-N, N', N'', N'''-tetraacetylchitotetraoside
Sign In for Pricing
View Details orb2940877-03 100 mg
4-Methylumbelliferyl β-D-N, N', N'', N'''-tetraacetylchitotetraoside
Sign In for Pricing
View Details